Orion Corporation et al v. Hetero USA Inc. et al
| Orion Corporation, Bayer Consumer Care AG, Bayer Healthcare LLC and Bayer HealthCare Pharmaceuticals Inc. |
| Hetero USA Inc., Hetero Labs Ltd., Unit-V and Hetero Labs Ltd. |
| 1:2023cv01221 |
| October 26, 2023 |
| U.S. District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 1 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 14, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 11 WAIVER OF SERVICE returned executed by Orion Corporation, Bayer HealthCare Pharmaceuticals Inc., Bayer HealthCare LLC, Bayer Consumer Care AG: For Hetero USA Inc. waiver sent on 10/31/2023, answer due 1/29/2024. (Fahnestock, Derek) |
| Filing 10 WAIVER OF SERVICE returned executed by Orion Corporation, Bayer HealthCare Pharmaceuticals Inc., Bayer HealthCare LLC, Bayer Consumer Care AG: For Hetero Labs Ltd., Unit-V waiver sent on 10/31/2023, answer due 1/29/2024. (Fahnestock, Derek) |
| Filing 9 WAIVER OF SERVICE returned executed by Orion Corporation, Bayer HealthCare Pharmaceuticals Inc., Bayer HealthCare LLC, Bayer Consumer Care AG: For Hetero Labs Ltd. waiver sent on 10/31/2023, answer due 1/29/2024. (Fahnestock, Derek) |
| Filing 8 STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (nms) |
| Filing 7 Summons Issued as to Hetero Labs Ltd. on 10/26/2023; Hetero Labs Ltd., Unit-V on 10/26/2023; and Hetero USA Inc. on 10/26/2023. (Attachments: #1 Summons Issued, #2 Summons Issued)(mkr) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG, for Bayer Consumer Care AG, Bayer HealthCare Pharmaceuticals Inc., and Bayer HealthCare LLC filed by Bayer Consumer Care AG, Bayer HealthCare Pharmaceuticals Inc., and Bayer Healthcare LLC. (mkr) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Orion Corporation. (mkr) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,010,530 B2; 10,383,853 B2; 10,835,515 B2; 11,168,058 B2. (mkr) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: On or about September 12, 2023. Date of Expiration of Patent: U.S. Patent No. 10,010,530 expires on 01/28/2036; U.S. Patent No. 10,383,853 expires on 01/28/2036; U.S. Patent No. 10,835,515 expires on 01/28/2036; and U.S. Patent No. 11,168,058 expires on 02/27/2038.Thirty Month Stay Deadline: on or about January 30, 2027. (mkr) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) |
| Filing 1 COMPLAINT filed against Hetero Labs Ltd., Hetero Labs Ltd., Unit-V, and Hetero USA Inc. (Filing fee $ 402, receipt number ADEDC-4258469.) - filed by Orion Corporation, Bayer HealthCare Pharmaceuticals Inc., Bayer HealthCare LLC, and Bayer Consumer Care AG. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Civil Cover Sheet)(mkr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
